Traders are betting Netflix's stock drama may be coming to an end
Current options prices are implying a 9% post-earnings move for Netflix, which is the highest since its Q3 2022 report, when it was priced for an 11% move.
International news in seven languages
Current options prices are implying a 9% post-earnings move for Netflix, which is the highest since its Q3 2022 report, when it was priced for an 11% move.
Democrats are hopeful that they will regain majority control of the House of Representatives and the Senate in November's elections.
Housing data deteriorated further in September, according to separate reports Tuesday.
The long-awaited decision about the controversial North Sea field is expected on Wednesday morning.
The performance of Amazon Web Services is the key.
Elon Musk's planned SpaceX stock donation could come with strings attached if he uses Trump Accounts. New Treasury rules limit when shares can be sold.
A new lawsuit challenges President Donald Trump's tariffs on a range of Canadian goods using Section 338 of the Tariff Act of 1930.
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Wall Street and investors will be looking for Netflix to provide additional details about the company's strategy following recent organizational changes
Germany's far-right AfD has launched an inquiry after the release of thousands of emails following a cyberattack. Also, investors pledged billions for Germany at a major summit in Berlin. DW has more news from Germany.
The bank says workers will be required to attend the office at least two days a week from February.
The primary headwind for Apple is valuation.
It's been a busy three months for SpaceX. Traders think that means more gains for the stock after it reports earnings after the bell today.
Anthropic and Nscale previously inked a similar deal for a data center on the same site in the U.S.
The key level traders are watching on the S&P 500 that could mean an even bigger decline is ahead.
New data on the housing market's performance in September is bleak, with sales, construction and sentiment all falling more than expected.
Neocloud stocks are still feeling the squeeze after last week's sell-off
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
The company's latest acquisition is expected to close in fiscal 2028, and will see Braze shareholders receive $47.50 in cash per share.
Former OpenAI executive Bob McGrew is launching Arda at a $1.5 billion.